Abstract Body

Background: Combination antiretroviral therapy (cART) suppresses but does not eradicate HIV infection. Analysis of HIV variants during cART has revealed populations of identical sequences, suggestive of clonally expanded populations, which have been found in plasma, in peripheral blood mononuclear cells (PBMC), as well as in anatomic compartments. HIV emerges rapidly after treatment interruption; rebound viremia also includes clonally expanded populations, but it is not known whether these clonal variants arise from persistent viremia during suppression, or from clonal sequences present in PBMC. To investigate the source of early rebound virus, we compared HIV in plasma and cells prior to and following a short structured treatment interruption (STI). Methodology: Stored plasma and PBMCs were obtained from patients (N=13) with viremia <50 c/ml on cART for ≥1 y enrolled in a STI. PBMCs were obtained on the day of drug interruption, and plasma samples obtained prior to and 7, 14, and 28 days after STI. DNA from PBMC and RNA from plasma was subjected to single genome sequencing (SGS) to obtain pro-RT sequences, which were aligned by Clustal W; phylogenetic analyses were performed using MEGA 5.2. Results: A total of 13 patients were enrolled (median age 38.7 y, CD4= 611 cells/μl, 39%, duration of suppression 2.7 y prior to STI); 6 patients have been analyzed and 467 SGS obtained thus far. Prior to STI, HIV population structure in PBMC was complex, and included groups of identical sequences in 5 of 6 patients as well as individual variants; viral populations in plasma prior to STI were more restricted with a limited number of variants detected. All patients rebounded within 7-14 days of treatment interruption. As expected, rebound viremia consisted of both individual variants and groups of identical sequences in all patients. In 2 of 6 patients, sequences present during rebound were identical to an HIV variant detected in plasma prior to the STI. In contrast, variants present in rebound viremia were only rarely detected in PBMC-derived DNA. Conclusions: Early rebound HIV consisted of individual and clonal sequences. PBMC populations were diverse and included clonal sequences. Rebound viremia included clonal sequences, but these populations were distinct from those detected in PBMC, and clonal sequences in PBMC did not give rise to clonal sequences in rebound viremia. These data suggest PBMC associated populations are large and diverse, and rebound viremia likely emerges from a small minority of infected cells. Some variants present in rebound viremia were detected in plasma prior to STI, demonstrating that rebound viremia emerges, at least in part, from expansion of low-level persistent viremia.